Optimal dosage of cefmetazole for intraoperative antimicrobial prophylaxis in patients undergoing surgery for colorectal cancer

Abstract

BACKGROUND: Few studies have reported the dosage of cefmetazole (CMZ) for intraoperative antimicrobial prophylaxis in patients underwent surgery for colorectal cancer. We therefore examined the optimal intraoperative dosage of CMZ according to pharmacokinetic/pharmacodynamic (PK/PD) theory in patients who undergoing surgery for colorectal cancer., METHODS: The study group comprised 23 patients with colorectal cancer who underwent surgery, using CMZ as antimicrobial treatment to prevent postoperative infection. CMZ was administered intravenously within 60 min before surgery. PK/PD analysis was performed by population pharmacokinetic analysis and Monte-Carlo simulation., RESULTS: The final population pharmacokinetic parameters of CMZ were as follows: CLCMZ=0.0704xcreatinine clearance (Ccr) and VdCMZ=0.163xbody weight (Bw). In patients with a Ccr of >=90 to <130 mL/min, the probability of achieving concentrations exceeding MIC was 52.9 to 82.2% at 2 h after the initial dose and less than 20% at 3 h after the initial dose., CONCLUSIONS: Additional doses of CMZ should be given every 2 h in patients with a Ccr of >=90 to <130 mL/min, every 3 h in those with a Ccr of >=50 to <90 mL/min, and every 4 to 5 h in those with a Ccr of >=10 to <50 mL/min.